Kintor Pharma Announces Successful Completion of Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US

DJ Kintor Pharma Announces Successful Completion of Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US EQS Newswire / 12/05/2023 / 09:49 UTC+8 Kintor Pharma Announces

Related Keywords

China ,Suzhou ,Jiangsu , ,Kintor Pharmaceutical ,Kintor Pharmaceutical Limited Pharma ,Financial Press ,Pharma Announces Successful Completion ,Androgenetic Alopecia ,Pharmaceutical Limited ,Kintor Pharma Announces Successful Completion ,Financial Press Release ,Dow Jones Newswires ,Gefallene Big Techs ,Ukintor ,Dharma ,Nnounces ,Uccessful ,Completion ,Hase ,Linical ,Trial ,Treatment ,Androgenetic ,Alopecia ,